Literature DB >> 34913751

Exploring Microenvironment Strategies to Delay Mesenchymal Stem Cell Senescence.

Xunhui Guo1,2, Jiayi Wang1,2, Wei Zou3,4, Wenjuan Wei1,2, Xin Guan1,2, Jing Liu1,2,3.   

Abstract

Mesenchymal stem cells (MSCs) have recently emerged as an important candidate for cell therapy and tissue regeneration. However, some limitations in translational research and therapies still exist, such as insufficient cell supply, inadequate differentiation potential, and decreased immune capacity, all of which result from replicative senescence during long-term in vitro culture. In vitro, stem cells lack a protective microenvironment owing to the absence of physical and biochemical cues compared with the in vivo niche, which provides dynamic physicochemical and biological cues. This difference results in accelerated aging after long-term in vitro culture. Therefore, it remains a great challenge to delay replicative senescence in culture. Constructing a microenvironment to delay replicative senescence of MSCs by maintaining their phenotypes, properties, and functions is a feasible strategy to solve this problem, and has made measurable progress both in preclinical studies and in clinical trials. Here, we review the current knowledge on the characteristics of senescent MSCs, explore the molecular mechanisms of MSCs senescence, describe the niche of MSCs, and discuss some current microenvironment strategies to delay MSCs replicative senescence that can broaden their range of therapeutic applications.

Entities:  

Keywords:  mesenchymal stem cells; microenvironment; senescence; strategies

Mesh:

Year:  2022        PMID: 34913751     DOI: 10.1089/scd.2021.0254

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  2 in total

1.  Lipoaspirate Shows In Vitro Potential for Wound Healing.

Authors:  Chiara Ceresa; Alessia Borrone; Letizia Fracchia; Maurizio Rinaldi; Alice Marchetti; Carlo Tremolada; Michela Bosetti
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

2.  CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells.

Authors:  Rose Triantafillia Psaroudis; Urvashi Singh; Maximilien Lora; Peter Jeon; Abigail Boursiquot; Ursula Stochaj; David Langlais; Inés Colmegna
Journal:  Stem Cell Res Ther       Date:  2022-07-26       Impact factor: 8.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.